Selected Publications

Academic Article

Year Title Altmetric
2017 Amygdalar expression of the microRNA miR-101a and its target Ezh2 contribute to rodent anxiety-like behaviourEuropean Journal of Neuroscience.  46:2241-2252. 2017
2016 Changes in clinical context for Kaposi's sarcoma and non-Hodgkin lymphoma among people with HIV infection in the United StatesJournal of Clinical Oncology.  34:3276-3283. 2016
2015 Point mutations of the mTOR-RHEB pathway in renal cell carcinomaOncotarget.  6:17895-17910. 2015
2014 Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathwaysPLoS ONE.  9. 2014
2014 Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responsesJournal of Immunology.  193:5604-5612. 2014
2014 Development and characterization of monoclonal antibodies to detect KlothoMonoclonal Antibodies in Immunodiagnosis and Immunotherapy.  33:420-427. 2014
2014 Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cellsJournal of Neurochemistry.  128:950-961. 2014
2013 Unfolded protein response (UPR) signaling regulates arsenic trioxide-mediated macrophage innate immune function disruptionToxicology and Applied Pharmacology.  272:879-887. 2013
2013 Identification of a high-mannose ICAM-1 glycoform: Effects of ICAM-1 hypoglycosylation on monocyte adhesion and outside in signalingAmerican Journal of Physiology - Cell Physiology.  305. 2013
2013 Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine modelToxicology and Applied Pharmacology.  266:233-244. 2013
2012 CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stressPLoS ONE.  7. 2012
2011 The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latencyFuture Microbiology.  6:1399-1413. 2011
2010 Lysosome dysfunction triggers Atg7-dependent neural apoptosisJournal of Biological Chemistry.  285:10497-10507. 2010
2010 Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cellsJournal of Virology.  84:3162-3177. 2010
2009 Bcl-2/adenovirus E1B 19-kd interacting protein 3 (BNIP3) regulates hypoxia-induced neural precursor cell deathJournal of Neuropathology and Experimental Neurology.  68:1326-1338. 2009
2007 Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA bindingJournal of Virology.  81:4348-4356. 2007
2007 Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomesVirology.  357:149-157. 2007
2007 RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNABBA - Gene Structure and Expression.  1769:29-40. 2007
2006 Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesJournal of Virology.  80:8909-8919. 2006
2004 Definition of sequence requirements for latency-associated nuclear antigen 1 binding to Kaposi's sarcoma-associated herpesvirus DNAJournal of Virology.  78:14033-14038. 2004
2004 KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistenceVirology.  319:225-236. 2004
2004 The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 N Terminus Is Essential for Chromosome Association, DNA Replication, and Episome PersistenceJournal of Virology.  78:294-301. 2004
2002 The KSHV latency-associated nuclear antigen: a multifunctional protein.Frontiers in Bioscience.  7. 2002
2001 Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNAJournal of Virology.  75:3250-3258. 2001
2001 The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigenViral Immunology.  14:311-317. 2001
1999 Erratum: (Science (April 23, 1999) (548-549))Science.  284:1623. 1999
1999 Efficient persistence of extrachromosomal KSHV DNA mediated by latency- associated nuclear antigenScience.  284:641-644. 1999
1998 Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipientNew England Journal of Medicine.  339:444-449. 1998
1997 Elevation of cyclic AMP levels in astrocytes antagonizes cytokine- induced adhesion molecule expressionJournal of Neurochemistry.  69:1438-1448. 1997
1995 Interleukin 1‐β‐ and tumor necrosis factor‐α‐mediated regulation of ICAM‐1 gene expression in astrocytes requires protein kinase C activityGlia.  14:267-278. 1995
1995 Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous systemBrain, Behavior, and Immunity.  9:304-314. 1995
1994 Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytesJournal of Neuroimmunology.  51:209-220. 1994

Full Name

  • Mary Ballestas